Volume 28, Issue 12, Pages (December 2016)

Slides:

Advertisements

Similar presentations

The evolving role of MDCT in the assessment of patients with chronic obstructive pulmonary disease S. Karia, R. Mahadeva, A. Balan, J. Babar Clinical Radiology.

Advertisements

Prognostic Models Predicting Survival of Patients with Brain Metastases: Integration of Lactate Dehydrogenase, Albumin and Extracranial Organ Involvement.

External Beam Radiotherapy for Differentiated Thyroid Cancer

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Nicoletta Colombo, Martin Gore

A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.

Recommendations for the Use of Radiotherapy in Nodal Lymphoma

Emerging treatment strategies in recurrent platinum-sensitive ovarian cancer: Focus on trabectedin Andrés Poveda, Isabelle Ray-Coquard, Ignacio Romero,

Treatment of stage I NSCLC in elderly patients: A population-based matched-pair comparison of stereotactic radiotherapy versus surgery David Palma, Otto.

The effect of perioperative chemotherapy for patients with an adenocarcinoma of the gastroesophageal junction: A propensity score matched analysis K.

Managing Cancer Pain: Basic Principles and Invasive Treatments

Elizabeth A. David, MD, David T

Volume 63, Issue 5, Pages (May 2013)

European Urology Oncology

Impact of acellular mucin pools on survival in patients with complete pathological response to neoadjuvant treatment in rectal cancer Abu Bakar Hafeez.

Sarcopenia is a prognostic factor for overall survival in patients with critical limb ischemia Yutaka Matsubara, MD, Takuya Matsumoto, MD, PhD, Yukihiko.

European Urology Oncology

Surgical Management of Advanced Non-Small Cell Lung Cancer Is Decreasing But Is Associated With Improved Survival Elizabeth A. David, MD, Robert J. Canter,

Chun Chieh Lin, PhD, MBA, Matthew P

Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis C.-C. Shu, J.-T. Wang, J.-Y. Wang, C.-J. Yu,

Joshua E. Rosen, BASc, Hari B

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 61, Issue 6, Pages (June 2012)

Volume 64, Issue 3, Pages (September 2013)

Hepatic resection of non-colorectal and non-neuroendocrine liver metastases – Survival benefit for patients with non-gastrointestinal primary cancers.

Volume 148, Issue 1, Pages (January 2018)

Pain in cancer survivors; filling in the gaps

Incidence and Survival of Malignant Pleural Mesothelioma in Norway: A Population- Based Study of 1686 Cases Åslaug Helland, MD, PhD, Steinar Solberg,

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,

Long-term Recurrence-free Survival After Standard Endoscopic Resection Versus Surgical Resection of Submucosal Invasive Colorectal Cancer: A Population-based.

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

Treatment and Prognosis of Isolated Local Relapse after Stereotactic Body Radiotherapy for Clinical Stage I Non-Small-Cell Lung Cancer Masatsugu Hamaji,

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA Nawar Hanna, Quoc-Dien Trinh,

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

National trends in management of stage IIIC1 and IIIC2 uterine cancer: Chemotherapy and radiotherapy in isolation and sequence J. Chino, J.R. Foote,

Pathologic response at interval debulking surgery following neoadjuvant chemotherapy predicts improved survival in women with ovarian cancer E.N. Prendergast,

The predictive value of nadir neutrophil count during treatment of cervical cancer: Interactions with tumor hypoxia and interstitial fluid pressure (IFP)

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Increasing Rates of No Treatment in Advanced-Stage Non–Small Cell Lung Cancer Patients: A Propensity-Matched Analysis Elizabeth A. David, MD, Megan E.

Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel M. Weinberger, S. Yaron, V. Agmon, R. Yishai, A.

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Concurrent chemotherapy and intensity modulated radiation therapy in the treatment of anal cancer: A retrospective review from a large academic center

Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case–control study H.A. Torres, E. Aguilera, A. Safdar,

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer Thomas W Rice, MD, David J Adelstein, MD, Jay P Ciezki,

Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients Valerie Waters, Eshetu G. Atenafu, Annie.

Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.

Clinical Relevance of Our Multimodality Prognostic Score

Conditional Survival of Malignant Thymoma Using National Population-Based Surveillance, Epidemiology, and End Results (SEER) Registry (1973–2011) Ellen.

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

Reviewer Acknowledgment

Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base Susan E. Combs, MA, Jacquelyn.

Stephen R. Broderick, MD, MPHS, Aalok P. Patel, BS, BA, Traves D

James D Luketich, Michael E Burt The Annals of Thoracic Surgery

Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer Eun Young Kim, MD, Young Saing Kim, MD, Inkeun Park, MD,

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Volume 54, Issue 1, Pages (July 2008)

Managing Cancer Pain: Basic Principles and Invasive Treatments

Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer D. Zylla, M.A. Kuskowski, K. Gupta, P. Gupta

Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery

Clinical Outcome After Pulmonary Resection for Lung Cancer Patients on Hemodialysis Toshiro Obuchi, MD, Wakako Hamanaka, MD, Yasuhiro Yoshida, MD, Jun.

Jamie E. Chaft, MD, Camelia S. Sima, MD, MS, Michelle S

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Visceral Pleural Invasion Is Not a Significant Prognostic Factor in Patients With a Part- Solid Lung Cancer Aritoshi Hattori, MD, Kenji Suzuki, MD, Takeshi.

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Andreas Granetzny, MD,

Presentation transcript:

Volume 28, Issue 12, Pages 790-796 (December 2016) Association between the Absolute Baseline Lymphocyte Count and Response to Neoadjuvant Platinum-based Chemotherapy in Muscle-invasive Bladder Cancer R. Leibowitz-Amit, A. Israel, M. Gal, E.A. Atenafu, Z. Symon, O. Portnoy, M. Laufer, Z. Dotan, J. Ramon, D. Avni, E. Fridman, R. Berger Clinical Oncology Volume 28, Issue 12, Pages 790-796 (December 2016) DOI: 10.1016/j.clon.2016.07.007 Copyright © 2016 The Royal College of Radiologists Terms and Conditions

Fig 1 Patient treatment allocation. Clinical Oncology 2016 28, 790-796DOI: (10.1016/j.clon.2016.07.007) Copyright © 2016 The Royal College of Radiologists Terms and Conditions

Fig 2 Overall survival curves of 'responders' and 'non-responders'. Survival in patients who achieved a pathological complete response (dotted red line) or did not achieve a pathological complete response (blue line) was calculated using the Kaplan–Meier analysis and compared using the Log-rank test. Clinical Oncology 2016 28, 790-796DOI: (10.1016/j.clon.2016.07.007) Copyright © 2016 The Royal College of Radiologists Terms and Conditions

Fig 3 Time trend of laboratory variables in 'responders' and 'non-responders'. The mean value at three time points (pre-neoadjuvant chemotherapy, pre-surgery and post-surgery) are shown with lines (blue: non-responders; red: responders), whereas individual values are depicted in dots. Clinical Oncology 2016 28, 790-796DOI: (10.1016/j.clon.2016.07.007) Copyright © 2016 The Royal College of Radiologists Terms and Conditions